Lis William 4
4 · Jasper Therapeutics, Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
Lis William
DirectorChief Executive Officer
Transactions
- Sale
Voting Common Stock
2022-06-27$2.08/sh−24,743$51,404→ 40,486 total - Sale
Voting Common Stock
2022-06-24$2.02/sh−24,743$50,030→ 65,229 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.88 to $2.24, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $2.30, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.